RECRUITINGOBSERVATIONAL
Gut Microbiota in the Progression of Alpha-synucleinopathies
Gut Microbiota in the Progression of Alpha-synucleinopathies: a Prospective Follow-up Study
About This Trial
The aim of this study is to correlate baseline gut microbiota features and the progression of neurodegeneration in the established cohort of patients with early Parkinson's disease.
Who May Be Eligible (Plain English)
Who May Qualify:
- recruit from the subjects who completed the baseline study
Who Should NOT Join This Trial:
- The use of probiotics or antibiotics within three months prior to sample collection;
- Pre-existing gastrointestinal diseases, such as inflammatory bowel disease.
- Not capable of giving willing to sign a consent form for participation of the study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* recruit from the subjects who completed the baseline study
Exclusion Criteria:
* The use of probiotics or antibiotics within three months prior to sample collection;
* Pre-existing gastrointestinal diseases, such as inflammatory bowel disease.
* Not capable of giving informed consent for participation of the study.
Treatments Being Tested
OTHER
No intervention
No intervention
Locations (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong